AD-2282
- Generic Name
- AD-2282
A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282
Phase 3
Not yet recruiting
- Conditions
- Primary Hypercholesterolemia
- Interventions
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT06747936
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath